Researchers at the Institut Pasteur, a Carnot-labeled institute, have developed an innovative technology: "lymphoid organ-on-chip" devices that are capable of simulating the human immune system’s response to booster vaccines. This breakthrough could provide a versatile preclinical system to evaluate vaccine candidates in the face of rapidly evolving pandemics such as that caused by the SARS-CoV-2 virus.

Find out more

llustration : Margaux Pailha EI